Related Experiment Video

Updated: May 9, 2026

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

Inhibition of LRRK2 kinase activity stimulates macroautophagy

Claudia Manzoni1, Adamantios Mamais2, Sybille Dihanich1

  • 1Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.

Biochimica Et Biophysica Acta
|August 7, 2013
PubMed

Insights

Inhibition of Leucine Rich Repeat Kinase 2 (LRRK2) kinase activity stimulates macroautophagy in brain cells. This suggests LRRK2 regulates autophagic vesicle formation independently of mTORC1 signaling, offering new therapeutic targets for Parkinson's disease.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Leucine Rich Repeat Kinase 2 (LRRK2) is a key genetic factor in Parkinson's disease.
  • LRRK2 is involved in cellular processes, including macroautophagy, the process cells use to clear damaged components.

Purpose of the Study:

  • To investigate the role of LRRK2 in regulating macroautophagy.
  • To determine if LRRK2 influences autophagy through the mTORC1 signaling pathway.

Main Methods:

  • Human neuroglioma cells were treated with a specific LRRK2 kinase inhibitor.
  • Downstream markers of macroautophagy and mTORC1 signaling were analyzed.

Main Results:

  • Inhibition of LRRK2 kinase activity significantly increased macroautophagy.
  • This stimulation occurred without affecting the translational targets of mTORC1.
  • LRRK2 appears to regulate autophagic vesicle formation independently of canonical mTORC1 signaling.

Conclusions:

  • This study provides the first pharmacological evidence that LRRK2 regulates the autophagy/lysosomal pathway.
  • LRRK2's role in autophagy is independent of mTORC1 signaling.
  • Understanding LRRK2's function in autophagy is crucial for developing targeted therapies for Parkinson's disease and related pathologies.
Keywords:
C-terminal of ROC domainCORDMSODPBSDimethylsulfoxideDulbecco's phosphate buffered salineEDTAEthylene di-ammonium tetra acetic acidLC3LRRK2Leucine Rich Repeat Kinase 2MacroautophagyMammalian target of rapamycinParkinson's diseaseROCRas of Complex ProteinsSDSSodium dodecyl sulphateWIPI2mTORp62

More Related Videos

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy09:29

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Published on: May 4, 2016

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...